Company Founder Takes the Helm of etectRx, a Digital Health Company GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of Eric Buffkin as its next president and CEO. etectRx received FDA clearance for its novel ingestible event marker, the ID-Cap™ System in late 2019,
GAINESVILLE, Fla. & BOSTON, Mass. (May 4, 2021) – Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy adherence among prescription opioid users living with HIV. The study, dubbed “MyTPill,” will assess patient adherence using two electronic adherence tracking technologies: the ID-Cap™ System from etectRx and an electronic
GAINESVILLE, Fla. (February 26, 2021) – Digital health company, etectRx, Inc., announced a signed letter of intent for a novel partnership with Local Health, Inc., a subsidiary of OneroRx, a leader in operating telepharmacies and community retail pharmacies. The partnership is structured to evaluate patient acceptability of the etectRx FDA-cleared digital pill ID-Cap™ System. Local
GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role, Standley’s main responsibility is setting the direction for the etectRx digital pill ID-Cap™ System. Standley’s onboarding aligns with recent etectRx partnerships with other digital health providers working toward providing solutions
GAINESVILLE, Fla. (January 14, 2021) – Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. The collaboration is the first of its kind to
GAINESVILLE, Fla. (October 7, 2020) – etectRx, Inc. recently announced that the United States Patent and Trademark Office has issued U.S. Patent 10,765,360 for an “Electronic medication compliance monitoring system and associated methods.” The patent supports the company’s existing intellectual property for its digital pill platform technology and methods for recording and tracking a patient’s adherence
ID-Cap™ System Will Allow Cliniciansto Remotely Track Ingestion Events and Provide Feedback to Patients GAINESVILLE, Fla. (September 10, 2020) – Digital health company etectRx™, Inc. (etectRx™), today announced that its FDA-cleared ingestible event marker, the ID-Cap™ System, will be utilized in a clinical study of 60 patients to develop programs aimed to improve medication adherence
Pharma Executive Brought in to Drive Digital Pill Use Cases GAINESVILLE, Fla. (August 20, 2020) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of pharma veteran Valerie Sullivan as its next president and CEO. In late 2019, the company received FDA clearance for its novel ingestible event marker, the ID-Cap™ System. etectRx is in dialogue with pharma companies to help drive commercialization for its novel technology. Sullivan, who
Announcement coincides with the issuance of two new U.S. Patents GAINESVILLE, Fla. (January 12, 2020) – etectRx™, Inc. (etectRx™), a privately-held digital health company, today announced the ID-Cap™ System is being utilized in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication. This collaborative
ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Fla. (December 9, 2019) – etectRx®, Inc. (etectRx), a privately-held digital health company, today announced U.S. Food and Drug Administration (FDA) clearance of its breakthrough patented ingestible event marker, the ID-Cap® System. The ID-Cap System is the first and only ingestible event marker
